A study that investigated the potential of the compound PRM-151 (PRM) for reducing progressive bone marrow fibrosis (scarring) in patients with advanced myelofibrosis has shown initial positive results. Myelofibrosis is a ...
A multicenter phase 1 trial of the immune checkpoint blocker ipilimumab found clinical benefit in nearly half of blood cancer patients who had relapsed following allogeneic stem cell transplantation, according to investigators ...
Heart disease patients have been advised to avoid being outside during rush hour traffic in a paper published today in European Heart Journal. The position paper on air pollution and cardiovascular disease was written by ...
There is no need to spray insecticide on walls for malaria control when people sleep under treated bed nets, according to new research.
The system that allows patients rapid access to expensive new treatments lacks transparency and penalises small and low-income countries unable to negotiate lower prices with pharmaceutical manufacturers. Writing in the Journal ...
More than 6,300 people have now died from Ebola in the three hardest hit nations in west Africa, the World Health Organization said Monday, as Sierra Leone overtook Liberia as the country with the highest number of cases.
Patients with plasma cell dyscrasis have high amounts of an abnormal immunoglobulin, called a paraprotein, in their blood. While many patients have no outward symptoms, paraproteins can impair immune function, thicken blood, ...
When it comes to specialized cancer surgery, it's generally true that the more experienced the surgeon, the better the outcome. The same might hold true for radiation therapy used to treat head and neck cancer, according ...